Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

Clinical trial NCT00141011 · TERMINATED

Trial details

NCT number: NCT00141011
Sponsor: Neurobiological Technologies
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Stroke Cerebral Ischemia Brain Infarction

Start date: 2005-09-01
Primary completion: 2008-12-01
Enrollment: 277

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.